Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BICALUTAMIDE for Metastases to bone: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 38 adverse event reports in the FDA FAERS database where BICALUTAMIDE was used for Metastases to bone.

Most Reported Side Effects for BICALUTAMIDE

Side Effect Reports % Deaths Hosp.
Malignant neoplasm progression 352 8.7% 52 43
Prostatic specific antigen increased 322 7.9% 18 41
Drug ineffective 268 6.6% 46 38
Fatigue 258 6.4% 22 79
Prostate cancer 258 6.4% 35 74
Asthenia 223 5.5% 6 57
Hot flush 219 5.4% 10 21
Off label use 171 4.2% 21 51
Disease progression 169 4.2% 26 28
Anaemia 164 4.0% 35 86
Death 164 4.0% 164 24
Metastases to bone 164 4.0% 26 23
Dyspnoea 128 3.2% 15 61
Nausea 127 3.1% 5 45
Interstitial lung disease 118 2.9% 41 65

Other Indications for BICALUTAMIDE

Prostate cancer (1,832) Product used for unknown indication (732) Prostate cancer metastatic (338) Hormone-refractory prostate cancer (87) Antiandrogen therapy (45) Hormone-dependent prostate cancer (32) Salivary gland cancer (31) Prostatic specific antigen increased (25) Hormone therapy (21) Adenocarcinoma (20)

Other Drugs Used for Metastases to bone

DENOSUMAB (5,083) ZOLEDRONIC ACID (3,177) RADIUM RA-223 DICHLORIDE (1,501) PALBOCICLIB (556) CABOZANTINIB S-MALATE (514) ENZALUTAMIDE (439) XGEVA (412) RIBOCICLIB (383) LETROZOLE (263) CARBOPLATIN (254)

Related Pages

BICALUTAMIDE Full Profile All Metastases to bone Drugs BICALUTAMIDE Demographics BICALUTAMIDE Timeline